CytomX Therapeutics Inc.

NASDAQ: CTMX · Real-Time Price · USD
1.93
0.17 (9.66%)
At close: Aug 15, 2025, 3:59 PM
1.93
0.26%
After-hours: Aug 15, 2025, 07:54 PM EDT

CytomX Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
31.87M -569K -99.32M -83.61M
Depreciation & Amortization
146K 2.17M 2.44M 2.71M
Stock-Based Compensation
7.67M 8.56M 13.13M 13.17M
Other Working Capital
-126.45M -93.64M 4.47M -66.21M
Other Non-Cash Items
-1.12M -3.69M 3.62M 3.13M
Deferred Income Tax
n/a n/a n/a 272K
Change in Working Capital
-126.42M -62.51M -30.65M -54.7M
Operating Cash Flow
-86.23M -56.03M -110.79M -119.03M
Capital Expenditures
-310K -840K -1.74M -1.61M
Cash Acquisitions
n/a n/a n/a -24.1M
Purchase of Investments
-155.49M -424.83M n/a -99.9M
Sales Maturities Of Investments
255.5M 275M 100M 124M
Other Investing Acitivies
n/a n/a 100M 24.1M
Investing Cash Flow
99.7M -150.67M 98.26M 22.49M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
613K 30.23M 648K 2.5M
Financial Cash Flow
7.52M 30.23M 648K 110.21M
Net Cash Flow
20.99M -176.48M -11.88M 13.67M
Free Cash Flow
-86.54M -56.88M -112.53M -120.64M